Login to Your Account

Financings Roundup

Friday, July 8, 2011
Clarus Therapeutics Inc., of Northbrook, Ill., withdrew its filing for an initial public offering, stating that the terms currently obtainable in the public marketplace are not sufficiently attractive. The specialty pharma firm had previously hoped to sell 5 million shares for $11 to $13 apiece.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription